VEGF Inhibitors in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|12|3|387-394

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.12, Iss.3, 2006-01, pp. : 387-394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF Inhibitors and Prostate Cancer Therapy

By  

Current Molecular Pharmacology, Vol. 2, Iss. 2, 2009-06 ,pp. : 161-168

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging VEGF-receptor inhibitors for colorectal cancer

By Martinelli Erika   Troiani Teresa   Morgillo Floriana   Orditura Michele   De Vita Fernando   Belli Giulio   Ciardiello Fortunato  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 25-37

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibitors in Cancer Therapy

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 968-981

Bentham Science Publishers

Access to resources Recommend Favorite

Discussion of PARP inhibitors in cancer therapy

By Wielgos Monica   Yang Eddy S  

Pharmaceutical Patent Analyst, Vol. 2, Iss. 6, 2013-11 ,pp. : 755-766

Future Science

Access to resources Recommend Favorite

PARP inhibitors in cancer therapy: an update

By Papeo Gianluca   Casale Elena   Montagnoli Alessia   Cirla Alessandra  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 4, 2013-04 ,pp. : 503-514

Informa Healthcare

Access to resources Recommend Favorite